Jain Sunil, Santhosh Abhijith
Department of Paediatrics, Command Hospital (Northern Command), Jammu & Kashmir, India.
Medical Officer, Emergency Department, Command Hospital (Northern Command), Jammu & Kashmir, India.
Pediatric Health Med Ther. 2021 Mar 25;12:151-159. doi: 10.2147/PHMT.S294729. eCollection 2021.
Current recommendations for 'Febrile seizures' management include emergency first aid and treatment along with intermittent prophylaxis. Evidence of practices, efficacy, side-effects, and complications should lead to refined and rational management strategies.
Study of cases referred and treated at a tertiary level hospital, providing referral services to a large state in India. Evidence sought for the research questions identified, these were (i) immediate treatment: First aid components and practices; response to drug treatment (ii) intermittent prophylaxis: effectiveness, compliance, and side-effects (iii) complications arising due to treatment side-effects: quantifying the number of cases of CNS infections missed as a result of alterations in consciousness levels due to benzodiazepines.
A total of 85 febrile seizure cases were studied. Full correct "First Aid" was provided by only 13 parents. Total 35 cases (41.18%) had seizures lasting more than 05 minutes. Emergency treatment for these included rectal diazepam in 14 cases with 57.14% success in terminating seizure, and intranasal midazolam in 21 cases with 71.43% success. The cases with persisting seizures were managed as status epilepticus treatment algorithm. Intermittent prophylaxis prevented recurrence of seizures in 90%, however side-effects were reported in 36.36%. There was no case of CNS infection missed.
Safe and effective management strategy should include "Health education" for correct first aid and 'Protocols' for timely and correct emergency treatment by parents/pre-hospital teams/emergency duty doctors. Intermittent prophylaxis is effective but refinements needed to minimize side-effects. Vigilant clinical monitoring obviates the fear that treatment may mask CNS infection.
目前关于“热性惊厥”管理的建议包括急救和治疗以及间歇性预防。实践、疗效、副作用和并发症的证据应能促成更完善、合理的管理策略。
对一家为印度一个大邦提供转诊服务的三级医院转诊并接受治疗的病例进行研究。针对所确定的研究问题收集证据,这些问题包括:(i)即刻治疗:急救内容与实践;药物治疗反应(ii)间歇性预防:有效性、依从性和副作用(iii)治疗副作用引起的并发症:量化因苯二氮䓬类药物导致意识水平改变而漏诊的中枢神经系统感染病例数。
共研究了85例热性惊厥病例。只有13位家长提供了完全正确的“急救”。总共有35例(41.18%)惊厥持续超过5分钟。对这些病例的急救治疗包括14例使用直肠地西泮,终止惊厥成功率为57.14%,21例使用鼻内咪达唑仑,成功率为71.43%。持续惊厥的病例按照癫痫持续状态治疗方案进行处理。间歇性预防使90%的惊厥未复发,然而有36.36%的病例报告有副作用。没有漏诊中枢神经系统感染的病例。
安全有效的管理策略应包括针对正确急救的“健康教育”以及家长/院前团队/急诊值班医生进行及时正确急救的“方案”。间歇性预防有效,但需要改进以尽量减少副作用。 vigilant临床监测消除了对治疗可能掩盖中枢神经系统感染的担忧。 (原文中“vigilant”拼写有误,可能是“vigilant”,这里按正确理解翻译)